Table 1. Correlation between STIM1 expression and clinicopathological characteristics of 90 CRC.
| Variable | Number of cases | STIM1 immunostaining | P-value | |
|---|---|---|---|---|
| − | + | |||
| Age (years) | ||||
| ⩾60 | 66 (73.3%) | 18 | 48 | |
| <60 | 24 (26.7%) | 9 | 15 | 0.436 |
| Gender | ||||
| Male | 47 (52.2%) | 15 | 32 | |
| Female | 43 (47.8%) | 12 | 31 | 0.818 |
| Tumor size (cm) | ||||
| ⩾5 | 54 (55.6%) | 12 | 42 | |
| <5 | 36 (44.4%) | 15 | 21 | 0.062 |
| TNM stage | ||||
| Stage I/II | 56 (62.2%) | 24 | 32 | |
| Stage III/IV | 34 (27.8%) | 3 | 31 | 0.001 |
| Lymph node status | ||||
| No metastasis | 57 (63.3%) | 22 | 35 | |
| Metastasis | 33 (36.7%) | 5 | 28 | 0.031 |
Abbreviations: CRC, colorectal cancer; STIM1, stromal interaction molecule 1; TNM, tumor node metastasis.